Every GLP-1 Provider We Have Scored

Highlights

• Ro offers a comprehensive Body Program focused on weight loss and GLP-1 medications.
• The company provides additional services like men’s sexual health, fertility support, and hair-loss treatments.
• Customers can access skincare products and general telemedicine through the platform.
• Founded in 2017, Ro operates from its headquarters in New York City.
• Ro emphasizes direct-to-consumer (DTC) sales, making health services easily accessible online.
• Maintains an informative Health Guide blog and publishes clinical research to support its offerings.

Why it ranks here

Ro ranks in the upper-middle tier: it is a licensed telehealth company dispensing genuine FDA-approved GLP-1s rather than relying primarily on compounded semaglutide — which strengthens its legitimacy and sourcing scores. It is more transparent than most compounders on pricing structure and eligibility. It is pulled down by a middling Trustpilot score (~3.7-3.8), persistent recurring-billing and cancellation complaints (BBB B rating), a membership-plus-medication cost stack that adds up, and unnamed/opaque pharmacy and clinician detail.

Pricing

Highlights

• Track your food intake with the easy-to-use Points® System.
• Access a list of ZeroPoint™ foods, allowing you to fill your plate freely.
• Get personal support through 24/7 Coaching Chat for instant advice.
• Join virtual or in-person workshops to connect and learn with others.
• Use various app modes tailored to different health needs like diabetes and pregnancy.
• Shop for healthy snacks, kitchen tools, and cookbooks directly from the app.

Why it ranks here

WeightWatchers ranks on the strength of genuine institutional legitimacy (public company, 60+ year brand, ABOM-certified clinicians) and a best-in-class behavioral care model wrapped around FDA-approved brand-name GLP-1s sourced through retail/insurance and direct-manufacturer pharmacies (Amazon Pharmacy, LillyDirect, NovoCare) rather than compounded formulations. It is a program-with-bolted-on-clinic, not a pure prescribing clinic, so its all-in cost is opaque (membership + separately-billed medication) and its GLP-1-specific autonomy is constrained to standard manufacturer titration. It is pulled down by punitive 12-month contract/cancellation policies, heavy billing complaints, past data-privacy litigation (a 2022 VPPA tracking-pixel suit, later voluntarily dismissed), and the 2025 Chapter 11 restructuring.

Pricing

Highlights

• Fridays launched in 2023, offering fresh solutions for weight loss.
• Based in Irvine, California, at the heart of digital health innovation.
• Specializes in medical weight loss programs with GLP-1 agonist prescriptions.
• Operates as a Software-as-a-Service (SaaS), making it accessible online.
• Users benefit from mental-health coaching and nutritional support alongside their weight loss journey.
• The SESH™ App helps users stay fit while coordinating insurance prior authorizations seamlessly.

Why it ranks here

Fridays ranks in the upper-middle on the strength of transparent flat-fee pricing, a clinician network (OpenLoop), publicly disclosed compounding-pharmacy partners, and a strong high-volume Trustpilot profile (4.5/5, ~4,470 reviews). It is held back by real opacity gaps (no named prescribing clinicians, no published contraindication/age criteria, a low BMI>=25 floor), consumer-unfriendly refund terms, and a BBB F rating tied to unanswered complaints. Not named in the Sept-2025 FDA warning-letter wave.

Pricing

Highlights

• A subscription-based platform focused on obesity medicine, making weight management accessible.
• Telehealth options let users connect with healthcare professionals from home.
• Founded by Dr. Myra Ahmad, the company emphasizes expert guidance and support for its users.
• Operates through Aequita Pharmacy, ensuring easy access to medications as needed.
• Services are available in all 50 U.S. states without geographic restrictions.
• Combines digital health technology with personalized care tailored to individual needs.

Why it ranks here

Mochi scores in the mixed-to-solid band on consumer-facing factors - transparent flat cash-pay pricing, a strong Trustpilot profile (4.4 across ~15,600 reviews), and a genuinely clinical model (mandatory live video consult with board-certified obesity-medicine providers plus registered dietitians, not a rubber-stamp questionnaire). It is pulled down materially by a MAJOR safety/quality event: its own/affiliated Kirkland WA compounder Aequita Pharmacy received a Washington DOH Limited Stop Service order in March 2025 (sterile-compounding deficiencies, untrained staff; reporting of unlicensed day-labor handling, glass-particle contamination, expired vials, improper cold-chain, patient adverse events) and closed in 2025, plus Eli Lilly and Novo Nordisk deceptive-marketing lawsuits and a pattern of cancellation/refund complaints. The safety record, not the marketing suits, is the primary drag.

Pricing

Why it ranks here

Gala publishes a price and, on the GLP-1 line, the screening criteria before signup, which lifts it above most of this category on transparency. It is held back by naming no compounding pharmacy and no clinician on any line, by medical-school logos it publishes nothing to support, and by menopause pages that carry unsourced outcome percentages and never state whether the hormones are FDA-approved or compounded.

Pricing

Why it ranks here

Embody sits mid-table. It is unusually open about the things most of this category hides — it names its operating company, names four dispensing pharmacies with addresses, and publishes every price tier as a public product page with no membership charge — and the FDA's enforcement register and the federal court docket both return nothing for it. It is pulled down by a refund policy that returns nothing once payment is submitted except on provider-initiated medical disqualification, by a qualifying consultation that happens after checkout rather than before, and by withholding the list of states it serves and any dose or titration detail.

Pricing

Highlights

• Noom Weight combines daily lessons and engaging challenges to keep users motivated.
• Users can track food intake, biometrics, and progress easily with built-in tracking tools.
• One-on-one coaching connects users with guides who provide personalized support and encouragement.
• Integrates with popular health apps like Apple Health and Google Fit for a comprehensive experience.
• Noom Med offers clinical services like video consultations and medication management for holistic care.
• Ancillary programs like Noom Mood help users manage emotions through targeted lessons and coaching.

Why it ranks here

Noom ranks in the middle of the GLP-1 field: it is a large, legitimate, hugely popular brand with genuine strengths in behavioral coaching, access, and momentum, but its GLP-1 layer is a newer program-mediated add-on rather than a purpose-built clinic. Its GLP-1-specific factors (titration autonomy, pharmacy sourcing, named prescribers) are thin or opaque, and it carries a documented consumer-protection history - an auto-renewal/dark-pattern class-action settlement (amount unestablished) plus persistent billing-and-cancellation complaints - that weighs heavily on pricing transparency and policy fairness.

Pricing

Highlights

• Medications are specially made in licensed pharmacies for your needs.
• Treatment is delivered via a standard needle and syringe.
• Products ship quickly with FedEx or UPS, ensuring freshness.
• Each package includes insulation and gel ice packs to keep medications cold.
• Deliveries arrive at your door without needing a signature.
• The service focuses on delivering quality care right to you, easily.

Why it ranks here

SkinnyRx pairs strong volume-driven consumer ratings (Trustpilot ~4.7 across roughly 5,000 reviews) and fast, appointment-free access with material transparency and legal red flags: no named clinicians, a February 2026 FDA marketing/misbranding warning letter (industry-wide sweep), and a class action alleging deceptive marketing of oral tirzepatide and inadequate medical evaluation.

Pricing

Highlights

• Compounded semaglutide program; monthly price not verifiable from a retrievable source, and a previously stated flat-across-all-doses claim is withdrawn.
• Compounded tirzepatide program; monthly price not verifiable from a retrievable source, and a previously stated flat-across-all-doses claim is withdrawn.
• Telehealth consultations ensure convenient access to healthcare professionals from home.
• Every order includes overnight cold-chain shipping to guarantee medication quality and safety.
• Injection supplies come included, making it easy for patients to manage their treatment.
• Nationwide availability advertised; a specific 50-state clinician-coverage claim is withdrawn as unverifiable. Guidance from board-certified clinicians.

Why it ranks here

RemedyMeds pairs easy cancellation with a strong, high-volume consumer rating (4.6/5 across 13,216 Trustpilot reviews, 86% five-star). Its weaker points are disclosure, not legitimacy: it does not name its compounding pharmacy or publish 503A/503B status, its site shows unsourced media logos and contradictory '#1' marketing claims, and specific eligibility criteria are gated behind the intake quiz. The Sept-2025 FDA warning letter it received was a marketing/labeling action issued to 50+ compounders in the same wave — a minor, industry-wide signal, not a quality or safety finding. Care is delivered async by U.S.-licensed clinicians with fast fulfillment; the number of states served is not restated here (see gaps).

Pricing

Highlights

• A telehealth program that connects patients with physicians for weight loss support.
• Access to specialized compounded GLP-1 medications, enhancing treatment options.
• Patients receive personalized treatment plans tailored to their individual needs and goals.
• Ongoing patient support ensures guidance throughout the weight loss journey.
• Features branded GLP-1 medications like Ozempic® and Wegovy®, recognized for effectiveness.
• Operates entirely online, making it convenient to access services from anywhere.

Why it ranks here

MEDVi pairs genuine strengths (transparent published cash pricing, a LegitScript-certified/NABP-accredited compounding partner in Belmar, huge Trustpilot volume at ~4.4, month-to-month terms) against serious integrity gaps: a Feb 2026 FDA misbranding warning letter, reported AI-generated fake ads/reviews/doctor testimonials (which MEDVi attributes to an affiliate marketer), a ~716K-individual data breach at its infrastructure partner OpenLoop (HHS OCR portal), and heavy reliance on an aggressive affiliate funnel. It owns no pharmacy, employs no physicians, and holds no drug licenses.

Pricing

Highlights

• Sprout Health serves approximately 44 states in the US, making it widely accessible.
• Offers services to adults aged 18 and older who meet specific medical criteria for weight management.
• Ships compounded medication from a partner pharmacy we could not identify from its own site.
• Free expedited shipping ensures prompt delivery of medications within 2–4 business days.
• A simple online process allows users to cancel their service anytime without hassle.
• Refills need only a quick "Refill Intake" form after the third dose each month.

Why it ranks here

Sprout Health is a real operating GLP-1 telehealth brand with a company-asserted (but not independently verified) LegitScript certification, but it ranks in the mixed-to-lower tier because it carries a Sept 2025 FDA misbranding warning letter (marketing-only, industry-wide), an F BBB rating driven by unanswered complaints, mixed/negative Trustpilot sentiment, widely reported cancellation and shipping-delay problems, an async no-labs screening model, and homepage opacity around clinicians, eligibility criteria, and pharmacy identity.

Pricing

Why it ranks here

WellMedr discloses more of its supply chain and its billing rules than most of this category — it names its clinical network and its fulfilment pharmacy, publishes a Florida-statute weight-loss disclosure, and sets out its refund cut-offs precisely. It is held back by publishing no price before checkout, by taking payment before its own clinical review happens, and by three places where its own pages contradict each other.

Pricing